ARTICLE | Company News
Alnylam, RNAx deal
February 2, 2004 8:00 AM UTC
Alnylam business unit Ribopharma AG (Kulmbach, Germany) licensed to RNAx non-exclusive rights to IP covering the use of short double-stranded RNAs to elicit RNAi for use in RNAx's research services b...